SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001140361-24-031090
Filing Date
2024-06-24
Accepted
2024-06-24 16:05:46
Documents
14
Period of Report
2024-06-24
Items
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K ef20031626_8k.htm   iXBRL 8-K 53349
2 EXHIBIT 10.1 ef20031626_ex10-1.htm EX-10.1 8421
  Complete submission text file 0001140361-24-031090.txt   204530

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA pdsb-20240624.xsd EX-101.SCH 3871
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE pdsb-20240624_lab.xml EX-101.LAB 22691
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE pdsb-20240624_pre.xml EX-101.PRE 16556
17 EXTRACTED XBRL INSTANCE DOCUMENT ef20031626_8k_htm.xml XML 4237
Mailing Address 303A COLLEGE ROAD EAST PRINCETON NJ 08540
Business Address 303A COLLEGE ROAD EAST PRINCETON NJ 08540 800-208-3343
PDS Biotechnology Corp (Filer) CIK: 0001472091 (see all company filings)

IRS No.: 264231384 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37568 | Film No.: 241064285
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)